Titterton Lewis H jr — SEC insider filings
SEC reporting owner CIK 1499254. 55 insider filings on record with FilingPulse; latest filed 2026-10-26.
Transaction summary — filings shown
Covers the 50 most recent of 55 filings on record, filed 2021-06-02 to 2026-10-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 34 legs across 29 filings — 5,078,624 shares, $2,028,916 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: purchase of 4,761,905 shares @ $0.21 ($1,000,000) in PARKERVISION INC, filed 2025-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | Director | 41 | 33 legs · 316,719 sh · $1,028,916 | — | 23 |
| PARKERVISION INC (PRKR) | Director | 9 | 1 leg · 4,761,905 sh · $1,000,000 | — | 19 |
Insider filings — Titterton Lewis H jr
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-26 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 8,000 @ $2.98 | EDGAR |
| 2026-09-25 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 49,036 @ $2.69 | EDGAR |
| 2026-09-14 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $2.73 | EDGAR |
| 2026-07-20 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 12,000 @ $3.47 | EDGAR |
| 2026-07-16 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,797 @ $3.28 | EDGAR |
| 2026-06-17 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,836 @ $2.64 | EDGAR |
| 2026-01-26 | 4 | PARKERVISION INC (PRKR) | Grant/award (A): 370,000 (derivative) @ $0.24 | EDGAR |
| 2026-01-06 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 16,000 @ $2.92 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | PARKERVISION INC (PRKR) | Purchase (P): 4,761,905 @ $0.21 | EDGAR |
| 2025-10-07 | 4 | PARKERVISION INC (PRKR) | Option exercise (M): 525,000 @ $0.18 · Option exercise (M): 275,000 @ $0.20 · Option exercise (M): 525,000 (derivative) @ $0.18 · Option exercise (M): 275,000 (derivative) @ $0.20 | EDGAR |
| 2025-08-04 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $3.08 | EDGAR |
| 2025-07-15 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $3.14 | EDGAR |
| 2025-07-08 | 4 | PARKERVISION INC (PRKR) | Grant/award (A): 275,000 | EDGAR |
| 2025-05-09 | 4 | PARKERVISION INC (PRKR) | Conversion (C): 1,699,844 @ $0.13 · Conversion (C): 1,699,844 (derivative) @ $0.13 | EDGAR |
| 2025-01-27 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,000 @ $2.91 · Purchase (P): 1,000 @ $3 | EDGAR |
| 2025-01-23 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,000 @ $3.01 | EDGAR |
| 2025-01-22 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 6,000 @ $2.59 | EDGAR |
| 2025-01-17 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $2.57 | EDGAR |
| 2025-01-07 | 4 | PARKERVISION INC (PRKR) | Gift (G): 2,000,000 @ $0 | EDGAR |
| 2025-01-03 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-10-23 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 16,000 @ $2.58 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2024-09-25 | 4 | PARKERVISION INC (PRKR) | Grant/award (A): 29,413 @ $0.17 · Grant/award (A): 8,568 @ $0.17 · Conversion (C): 257,370 @ $0.10 · Conversion (C): 514,740 @ $0.10 · Conversion (C): 405,524 @ $0.13 · Conversion (C): 257,370 (derivative) @ $0.10 · +2 more | EDGAR |
| 2024-08-01 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 21,646 @ $3.06 · Purchase (P): 5,580 @ $3.23 | EDGAR |
| 2024-07-29 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 796 @ $2.81 · Purchase (P): 7,700 @ $3.03 | EDGAR |
| 2024-06-18 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 4,000 @ $2.68 | EDGAR |
| 2024-06-14 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 405 @ $2.70 | EDGAR |
| 2024-06-12 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 330 @ $2.60 · Purchase (P): 7,102 @ $2.66 | EDGAR |
| 2024-06-10 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,738 @ $2.52 | EDGAR |
| 2024-04-10 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 15,009 @ $3.28 | EDGAR |
| 2024-02-05 | 4 | PARKERVISION INC (PRKR) | Grant/award (A): 275,000 (derivative) @ $0.20 | EDGAR |
| 2024-01-16 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-11-22 | 4 | PARKERVISION INC (PRKR) | Grant/award (A): 600,000 (derivative) @ $0.18 | EDGAR |
| 2023-10-11 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 16,000 @ $2.58 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2023-07-31 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 120,000 @ $2.58 · Tax withholding (F): 87,042 @ $3.55 · Option exercise (M): 120,000 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-09-30 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 40,000 @ $2.58 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2022-09-16 | 4 | Anixa Biosciences Inc (ANIX) | Gift (G): 300,000 @ $0 | EDGAR |
| 2022-06-28 | 4 | Anixa Biosciences Inc (ANIX) | Option exercise (M): 30,000 @ $2.58 · Option exercise (M): 16,000 @ $2.58 · Option exercise (M): 30,000 (derivative) @ $0 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2022-04-27 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 10,000 @ $2.79 | EDGAR |
| 2022-03-11 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-01-13 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 5,000 @ $3.28 | EDGAR |
| 2022-01-12 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,000 @ $3.20 | EDGAR |
| 2022-01-11 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 6,000 @ $3.08 | EDGAR |
| 2022-01-10 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 11,000 @ $3.08 | EDGAR |
| 2021-11-01 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 18,244 @ $4.76 | EDGAR |
| 2021-07-28 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 30,000 @ $4.21 | EDGAR |
| 2021-07-19 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 2,200 @ $3.65 · Purchase (P): 10,000 @ $4.07 | EDGAR |
| 2021-07-15 | 4 | Anixa Biosciences Inc (ANIX) | Purchase (P): 23,300 @ $3.72 | EDGAR |
| 2021-06-02 | 4 | Anixa Biosciences Inc (ANIX) | Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1499254 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs